(Q42988446)

12 November 2017

Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. (English)

1 reference

12 November 2017

0 references

1 reference

1 reference

1 reference

8

1 reference

12 November 2017

Pessione F

1

1 reference

12 November 2017

Degos F

2

1 reference

12 November 2017

Marcellin P

3

1 reference

12 November 2017

Duchatelle V

4

1 reference

12 November 2017

Njapoum C

5

1 reference

12 November 2017

Martinot-Peignoux M

6

1 reference

12 November 2017

Degott C

7

1 reference

12 November 2017

Erlinger S

9

1 reference

12 November 2017

Rueff B

10

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 June 1998

1 reference

12 November 2017

1 reference

12 November 2017

27

1 reference

12 November 2017

1717-1722

1 reference

12 November 2017

6

1 reference

Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group

12 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270635

7 January 2021

Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270635

7 January 2021

Molecular epidemiology of hepatitis C virus infection among intravenous drug users.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270635

7 January 2021

Relationship between hepatitis C virus subtypes and clinical features of liver disease seen in alcoholics

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270635

7 January 2021

Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270635

7 January 2021

Hepatitis C viremia and anti-HCV antibodies in alcoholics

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270635

7 January 2021

Interest of the detection of hepatitis C virus RNA in patients with alcoholic liver disease. Comparison with the HBV status

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270635

7 January 2021

Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270635

7 January 2021

Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270635

7 January 2021

Alcohol intake increases human immunodeficiency virus type 1 replication in human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270635

7 January 2021

Variations in quantity-frequency measures of alcohol consumption from a general population survey.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270635

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270635

7 January 2021

Chronic hepatitis C: effect of alcohol on hepatitic activity and viral titre

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270635

7 January 2021

Serological and histological aspects of hepatitis C virus infection in alcoholic patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270635

7 January 2021

A histopathological study of alcoholics with chronic HCV infection: comparison with chronic hepatitis C and alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270635

7 January 2021

Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270635

7 January 2021

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270635

7 January 2021

Clinical outcomes after transfusion-associated hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270635

7 January 2021

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270635

7 January 2021

Genetic predispositions for immunological features in chronic liver diseases other than autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270635

7 January 2021

Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270635

7 January 2021

Long-term outcome of hepatitis C infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270635

7 January 2021

Altered immunity in male patients with alcoholic liver disease: evidence for defective immune regulation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270635

7 January 2021

National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270635

7 January 2021

Identifiers

DOI

10.1002/HEP.510270635

1 reference

12 November 2017

1 reference